Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Abbott India Ltd rose for a third straight session today. The stock is quoting at Rs 32815, up 3.58% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.53% on the day, quoting at 25378.3. The Sensex is at 83219.23, up 0.56%. Abbott India Ltd has added around 7.89% in last one month.
Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has added around 0.77% in last one month and is currently quoting at 21804.8, down 0.53% on the day. The volume in the stock stood at 18770 shares today, compared to the daily average of 8156 shares in last one month.
The PE of the stock is 47.61 based on TTM earnings ending March 25.
Abbott India Ltd gained for a fifth straight session today. The stock is quoting at Rs 31185, up 0.16% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.24% on the day, quoting at 24600.6. The Sensex is at 80971.74, up 0.29%. Abbott India Ltd has gained around 1.5% in last one month.
Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has gained around 1.86% in last one month and is currently quoting at 21354.2, up 0.08% on the day. The volume in the stock stood at 3824 shares today, compared to the daily average of 9658 shares in last one month.
The PE of the stock is 46.66 based on TTM earnings ending March 25.
Abbott India Ltd rose for a fifth straight session today. The stock is quoting at Rs 31190, up 1.12% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.39% on the day, quoting at 24780.3. The Sensex is at 81439.19, up 0.31%. Abbott India Ltd has added around 0.56% in last one month.
Meanwhile, Nifty Pharma index of which Abbott India Ltd is a constituent, has added around 1.38% in last one month and is currently quoting at 21456.15, up 1.3% on the day. The volume in the stock stood at 8113 shares today, compared to the daily average of 8871 shares in last one month.
The PE of the stock is 46.26 based on TTM earnings ending March 25.
For the full year,net profit rose 17.75% to Rs 1414.44 crore in the year ended March 2025 as against Rs 1201.22 crore during the previous year ended March 2024. Sales rose 9.58% to Rs 6409.15 crore in the year ended March 2025 as against Rs 5848.91 crore during the previous year ended March 2024.
Total expenses increased 6% to Rs 1,197.90 crore in Q4 FY25 as against Rs 1,130.10 crore posted in same quarter last year. Cost of material consumed stood at Rs 186.68 crore (up 15.38% YoY), employee benefit expense was at Rs 144.40 crore (down 0.58% YoY) and finance cost was at Rs 3.92 crore (up 39.5% YoY) during the period under review.
On full year basis, the company’s standalone net profit jumped 17.8% to Rs 1,414.44 crore on a 9.6% rise in revenue from operations to Rs 6,409.15 crore in FY25 over FY24.
Meanwhile, the company’s board recommended payment of final dividend of Rs 475 per equity share of Rs 10 each for FY25, subject to approval of shareholders at the ensuing Eighty-first annual general meeting of the company scheduled to be held on Wednesday, August 13, 2025. The company has fixed the record date as Friday, 25 July 2025.
The aforesaid final dividend, if approved by the members, will be paid on or after Monday, August 18, 2025.
Abbott India is a subsidiary of Abbott Laboratories, headquartered in Mumbai. The company provides products and solutions across various therapeutic areas including gastroenterology, women’s health, metabolics, central nervous system, vaccines and multi-specialty.